These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 26696207

  • 1. [Application value of fine needle aspiration and cell block in preoperative diagnosis of thyroid cancer and discrimination of follicular tumor].
    Fang Q, Cai C, Chen H.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Aug; 50(8):668-72. PubMed ID: 26696207
    [Abstract] [Full Text] [Related]

  • 2. Ultrasound Risk Assessment Combined with Molecular Markers of Galectin-3, c-MET, HBME-1 and CK19 for Diagnosis of Malignant and Benign Thyroid Nodules.
    Han RL, Wang J, Zhang FJ, Zhao N, Gao BL.
    Pathol Oncol Res; 2019 Jul; 25(3):1075-1081. PubMed ID: 30361909
    [Abstract] [Full Text] [Related]

  • 3. Improvement of the cytological diagnostic accuracy of follicular thyroid lesions by the use of the Ki-67 proliferative index in addition to cytokeratin-19 and HBME-1 immunomarkers: a study of 61 cases of liquid-based FNA cytology with histological controls.
    Lacoste-Collin L, d'Aure D, Bérard E, Rouquette I, Delisle MB, Courtade-Saïdi M.
    Cytopathology; 2014 Jun; 25(3):160-9. PubMed ID: 24460983
    [Abstract] [Full Text] [Related]

  • 4. Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas.
    Saggiorato E, Aversa S, Deandreis D, Arecco F, Mussa A, Puligheddu B, Cappia S, Conticello S, Papotti M, Orlandi F.
    J Endocrinol Invest; 2004 Apr; 27(4):311-7. PubMed ID: 15233548
    [Abstract] [Full Text] [Related]

  • 5. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
    Abd-El Raouf SM, Ibrahim TR.
    Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837
    [Abstract] [Full Text] [Related]

  • 6. The Role of CD56 in Thyroid Fine Needle Aspiration Cytology: A Pilot Study Performed on Liquid Based Cytology.
    Bizzarro T, Martini M, Marrocco C, D'Amato D, Traini E, Lombardi CP, Pontecorvi A, Fadda G, Larocca LM, Rossi ED.
    PLoS One; 2015 Dec; 10(7):e0132939. PubMed ID: 26186733
    [Abstract] [Full Text] [Related]

  • 7. [The frequency of malignant disease in cytological group of suspected cancer (ultrasound-guided fine-needle aspiration biopsy of nonpalpable thyroid nodules)].
    Miseikyte-Kaubriene E, Ulys A, Trakymas M.
    Medicina (Kaunas); 2008 Dec; 44(3):189-94. PubMed ID: 18413985
    [Abstract] [Full Text] [Related]

  • 8. Proteomic identification of new biomarkers and application in thyroid cytology.
    Torres-Cabala C, Bibbo M, Panizo-Santos A, Barazi H, Krutzsch H, Roberts DD, Merino MJ.
    Acta Cytol; 2006 Dec; 50(5):518-28. PubMed ID: 17017437
    [Abstract] [Full Text] [Related]

  • 9. [Expression of GADD153 in follicular tumors of thyroid and comparison with CK19, Galectin-3 and HBME-1].
    Tang QS, Teng XD, Ding W, Zhou J, Yao HT, Ying LX, Xu LM.
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):745-8. PubMed ID: 22336157
    [Abstract] [Full Text] [Related]

  • 10. Immunocytochemistry with cytokeratin 19 and anti-human mesothelial cell antibody (HBME1) increases the diagnostic accuracy of thyroid fine-needle aspirations: preliminary report of 150 liquid-based fine-needle aspirations with histological control.
    Cochand-Priollet B, Dahan H, Laloi-Michelin M, Polivka M, Saada M, Herman P, Guillausseau PJ, Hamzi L, Poté N, Sarfati E, Wassef M, Combe H, Raulic-Raimond D, Chedin P, Medeau V, Casanova D, Kania R.
    Thyroid; 2011 Oct; 21(10):1067-73. PubMed ID: 21875347
    [Abstract] [Full Text] [Related]

  • 11. A core needle biopsy provides more malignancy-specific results than fine-needle aspiration biopsy in thyroid nodules suspicious for malignancy.
    Hakala T, Kholová I, Sand J, Saaristo R, Kellokumpu-Lehtinen P.
    J Clin Pathol; 2013 Dec; 66(12):1046-50. PubMed ID: 23863219
    [Abstract] [Full Text] [Related]

  • 12. Differences of HBME-1 Expression in Thyroid Follicular Adenoma and Follicular Thyroid Carcinoma by Ultrasound-Guided Fine-Needle Aspiration Biopsy.
    Wang J, Xu L, Xu X, Wang X.
    J Coll Physicians Surg Pak; 2019 Apr; 29(4):337-340. PubMed ID: 30925956
    [Abstract] [Full Text] [Related]

  • 13. Diagnosis of suspicious thyroid nodules using four protein biomarkers.
    Cerutti JM, Latini FR, Nakabashi C, Delcelo R, Andrade VP, Amadei MJ, Maciel RM, Hojaij FC, Hollis D, Shoemaker J, Riggins GJ.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3311-8. PubMed ID: 16740752
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic value of TROP-2 expression in papillary thyroid carcinoma and comparison with HBME-1, galectin-3 and cytokeratin 19.
    Murtezaoglu AR, Gucer H.
    Pol J Pathol; 2017 Jun 01; 68(1):1-10. PubMed ID: 28547974
    [Abstract] [Full Text] [Related]

  • 15. Clinical impact of a cytological screening system using cyclin D1 immunostaining and genomic analysis for the diagnosis of thyroid nodules.
    Teshima M, Tokita K, Ryo E, Matsumoto F, Kondo M, Ikegami Y, Shinomiya H, Otsuki N, Hiraoka N, Nibu KI, Yoshimoto S, Mori T.
    BMC Cancer; 2019 Mar 18; 19(1):245. PubMed ID: 30885146
    [Abstract] [Full Text] [Related]

  • 16. Defining the value of CD56, CK19, Galectin 3 and HBME-1 in diagnosis of follicular cell derived lesions of thyroid with systematic review of literature.
    Dunđerović D, Lipkovski JM, Boričic I, Soldatović I, Božic V, Cvejić D, Tatić S.
    Diagn Pathol; 2015 Oct 26; 10():196. PubMed ID: 26503236
    [Abstract] [Full Text] [Related]

  • 17. Sonographically suspicious thyroid nodules with initially benign cytologic results: the role of a core needle biopsy.
    Ha EJ, Baek JH, Lee JH, Song DE, Kim JK, Shong YK, Hong SJ.
    Thyroid; 2013 Jun 26; 23(6):703-8. PubMed ID: 23544697
    [Abstract] [Full Text] [Related]

  • 18. IS MEASUREMENT OF CIRCULATING TUMOR DNA OF DIAGNOSTIC USE IN PATIENTS WITH THYROID NODULES?
    Lupo M, Guttler R, Geck Z, Tonozzi TR, Kammesheidt A, Braunstein GD.
    Endocr Pract; 2018 May 26; 24(5):453-459. PubMed ID: 29498908
    [Abstract] [Full Text] [Related]

  • 19. The diagnostic application of RNA sequencing in patients with thyroid cancer: an analysis of 851 variants and 133 fusions in 524 genes.
    Pagan M, Kloos RT, Lin CF, Travers KJ, Matsuzaki H, Tom EY, Kim SY, Wong MG, Stewart AC, Huang J, Walsh PS, Monroe RJ, Kennedy GC.
    BMC Bioinformatics; 2016 Jan 11; 17 Suppl 1(Suppl 1):6. PubMed ID: 26818556
    [Abstract] [Full Text] [Related]

  • 20. Utility of immunohistochemical markers in differentiating benign from malignant follicular-derived thyroid nodules.
    Saleh HA, Jin B, Barnwell J, Alzohaili O.
    Diagn Pathol; 2010 Jan 26; 5():9. PubMed ID: 20181018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.